Panbela provides business update and reports q2 2021 financial results

Minneapolis, aug. 11, 2021 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today provided a business update and reported financial results for the quarter ended june 30, 2021. management is hosting an earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking